Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection?

Indian J Med Res. 2023 Jan;157(1):100-103. doi: 10.4103/ijmr.ijmr_233_22.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adenosine Monophosphate
  • COVID-19 Drug Treatment
  • COVID-19*
  • Humans
  • Prodrugs*

Substances

  • remdesivir
  • Prodrugs
  • Adenosine Monophosphate